Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02175030 · ClinicalTrials.gov registry record · Phase 4
RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
A Phase 4 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 4
- Development phase
- 711
- Enrollment target
NCT02175030: Completed Phase 4 study, sponsored by University of Utah.
NCT02175030 is a Phase 4 study that has completed, run by University of Utah. The registered enrollment target is 711 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (37% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02175030, a Phase 4 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 711 participants
- Enrollment target
Study Summary
This study is a randomized trial of two IUDs for emergency contraception: the copper IUD, the most effective method of emergency contraception vs. the levonorgestrel IUD, the most preferred IUD which has never been tested as an emergency contraceptive. This research has the potential to increase use of highly effective contraception in a high-risk population and lower the persistently elevated rate of U.S. unintended pregnancy.
Primary Outcome
Urine pregnancy tests within 30 days after IUD insertion will be performed either at home or in clinic. We will use the total number of pregnancies per ARM and the overall number of participants analyzed per ARM to calculate, for each ARM, the percentage of participants reporting a pregnancy in the first month of use of the IUD.
Interventions
- DRUG Copper IUD
- DRUG Levonorgestrel IUD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 711 participants |
| Start Date | 2016-08 |
| Est. Completion | 2020-12 |
| Phase | Phase 4 |
What the finished NCT02175030 record still lists
NCT02175030 is an interventional study that assigns participants to a tested intervention. The registered 711 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (37% higher).
The record links to 0 conditions, and to 2 interventions - of which Copper IUD is the first listed.
NCT02175030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02175030 about?
NCT02175030 is a clinical study titled "RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC". This study is a randomized trial of two IUDs for emergency contraception: the copper IUD, the most effective method of emergency contraception vs. the levonorgestrel IUD, the most preferred IUD which has never been tested as an emergency contraceptive. This research has the potential to increase use...
What is the current status of trial NCT02175030?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 711 participants. The study started on 2016-08. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02175030?
The interventions under investigation include: Copper IUD (DRUG), Levonorgestrel IUD (DRUG).
Who is sponsoring clinical trial NCT02175030?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02175030's enrollment target sits among peer trials
711 114th of 2000 higher than 1,887 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06179160 · 710 participants · Phase 1
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- NCT06235697 · 710 participants · Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
- NCT06470867 · 710 participants · NA
Randomized Controlled Effectiveness Trial of VA S.A.V.E.
- NCT07022483 · 710 participants · Phase 3
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia